1. Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis. Issue 1 (9th May 2015) Authors: Reddy, K. Rajender; Bourlière, Marc; Sulkowski, Mark; Omata, Masao; Zeuzem, Stefan; Feld, Jordan J.; Lawitz, Eric; Marcellin, Patrick; Welzel, Tania M.; Hyland, Robert; Ding, Xiao; Yang, Jenny; Knox, Steven; Pang, Phillip; Dvory‐Sobol, Hadas; Subramanian, G. Mani; Symonds, William; McHutchison, J... Journal: Hepatology Issue: Volume 62:Issue 1(2015:Jul.) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lack of a clinically important pharmacokinetic interaction between sofosbuvir or ledipasvir and hormonal oral contraceptives norgestimate/ethinyl estradiol in HCV‐Uninfected female subjects. (24th June 2014) Authors: German, P.; Moorehead, L.; Pang, Phillip; Vimal, M.; Mathias, A. Journal: Journal of clinical pharmacology Issue: Volume 54:Number 11(2014:Nov.) Page Start: 1290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis. Issue 1 (9th May 2015) Authors: Reddy, K. Rajender; Bourlière, Marc; Sulkowski, Mark; Omata, Masao; Zeuzem, Stefan; Feld, Jordan J.; Lawitz, Eric; Marcellin, Patrick; Welzel, Tania M.; Hyland, Robert; Ding, Xiao; Yang, Jenny; Knox, Steven; Pang, Phillip; Dvory‐Sobol, Hadas; Subramanian, G. Mani; Symonds, William; McHutchison, J... Journal: Hepatology Issue: Volume 62:Issue 1(2015:Jul.) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗